DR SANDEEP RAI

About

I am PhD in Biotechnology with experience of more than 15 years in field of flow cytometry and leukemia. Development and standardization of flow cytometry panels for the analysis. Wide experience in maintaining and troubleshooting flow cytometers. Working on validation and Phd projects.

Employment

• All India Institute of Medical Sciences TECHNICAL OFFICER
  2007 - Present

Education

• Maharaj Vinayak Global University Phd
  2013 - 2016
• Hemwati Nandan Bahuguna Garhwal University MSc (Biotechnology)
  2003 - 2005
• University of Delhi BSc (Life Science)
  2000 - 2003

Projects & Funding

Projects & funding information is unavailable.

Publications (26)

• Hypoxia-Mediated Molecular Interactions of Tissue-Specific Mesenchymal Stem Cells Drive Metabolic Reprogramming and Immunomodulation in Acute Graft-versus-Host Disease
  2025 DOI: 10.1101/2025.01.06.630457
  +Save
• Machine Learning Algorithm-Based Prediction of Acute Graft-Versus-Host-Disease at Engraftment through Immune and Cytokine Profile
  Blood 2024 DOI: 10.1182/blood-2024-212351
  +Save
• Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model
  Stem Cell Research & Therapy 2024 DOI: 10.1186/s13287-024-03947-2
  +Save
• A Comparative assessment of T-Cell response of Healthy donors and Acute Graft-versus-Host-Disease Patients: Customizing immune monitoring platform
  2024 DOI: 10.1101/2024.09.05.611044
  +Save
• Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10‐colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity
  International Journal of Laboratory Hematology 2024 DOI: 10.1111/ijlh.14250
  +Save
• Acute myeloid leukemia with immunophenotype: A new underdiagnosed entity
  International Journal of Laboratory Hematology 2023 DOI: 10.1111/ijlh.14076
  +Save
• CD34 negative HLA-DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3-ITD mutations
  International Journal of Laboratory Hematology 2023 DOI: 10.1111/ijlh.14007
  +Save
• Utility of CD229 as novel marker in measurable residual disease assessment in multiple myeloma—An evidence-based approach
  International Journal of Laboratory Hematology 2023 DOI: 10.1111/ijlh.13992
  +Save
• Integrated single-cell transcriptome analysis of CD34 + enriched leukemic stem cells revealed intra- and inter-patient transcriptional heterogeneity in pediatric acute myeloid leukemia
  Annals of Hematology 2023 DOI: 10.1007/s00277-022-05021-4
  +Save
• Hypocellular AML versus MDS-diagnostic challenge case report with review of literature.
  American journal of blood research 2022
  +Save